There have been 25 recent insider transactions recorded for CollPlant Biotechnologies Ltd. (CLGN), including 0 buys and 0 sells.
Notable insiders with recent activity include Tal Yehiel, Rotem Eran, Penn Elan. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — CLGN
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-19 |
Tal Yehiel |
Chief Executive Officer |
Unknown |
- |
- |
- |
31,137 |
| 2026-03-18 |
Rotem Eran |
Deputy CEO and CFO |
Unknown |
- |
- |
- |
60,000 |
| 2026-03-18 |
Penn Elan |
Director |
Unknown |
- |
- |
- |
7,500 |
| 2026-03-18 |
Lask Alisa |
Director |
Unknown |
- |
- |
- |
10,000 |
| 2026-03-18 |
Havron Avraham |
Director |
Unknown |
- |
- |
- |
10,000 |
| 2026-03-18 |
Bensimon Philippe |
VP Regulations and Qa |
Unknown |
- |
- |
- |
2,000 |
| 2026-03-18 |
Fahimipoor Oren |
VP Operations |
Unknown |
- |
- |
- |
30,000 |
| 2026-03-18 |
Bagley Bowman |
VP Commercial North America |
Unknown |
- |
- |
- |
25,000 |
| 2026-03-18 |
Abelis Bar Berta |
VP Legal |
Unknown |
- |
- |
- |
13,000 |
| 2026-03-18 |
Seror Jasmine |
VP Product Development |
Unknown |
- |
- |
- |
12,000 |
| 2024-03-28 |
Fahimipoor Oren |
VP Operations |
Unknown |
50,000 |
$7.50 |
$375K |
- |
| 2024-03-28 |
Abelis Bar Berta |
VP Legal |
Unknown |
20,000 |
$7.50 |
$150K |
- |
| 2023-05-02 |
Penn Elan |
Director |
Unknown |
24,000 |
$6.39 |
$153.36K |
- |
| 2023-05-02 |
Lask Alisa |
Director |
Unknown |
47,000 |
$6.39 |
$300.33K |
- |
| 2023-05-02 |
Havron Avraham |
Director |
Unknown |
24,000 |
$6.39 |
$153.36K |
- |
| 2023-05-02 |
Tal Yehiel |
Chief Executive Officer |
Unknown |
100,000 |
$6.39 |
$639K |
- |
| 2023-01-27 |
Rotem Eran |
Deputy CEO and CFO |
Unknown |
80,000 |
$6.39 |
$511.2K |
- |
| 2023-01-27 |
Bensimon Philippe |
VP Regulations and Qa |
Unknown |
30,000 |
$6.39 |
$191.7K |
- |
| 2021-05-26 |
Seror Jasmine |
VP Product Development |
Unknown |
3,600 |
$6.39 |
$23K |
- |
| 2020-05-18 |
Tal Yehiel |
Chief Executive Officer |
Unknown |
37,800 |
$4.02 |
$151.96K |
- |
| 2019-01-14 |
Penn Elan |
Director |
Unknown |
10,000 |
$4.02 |
$40.2K |
- |
| 2019-01-14 |
Havron Avraham |
Director |
Unknown |
4,000 |
$4.02 |
$16.08K |
- |
| 2018-12-26 |
Bensimon Philippe |
VP Regulations and Qa |
Unknown |
15,000 |
$4.02 |
$60.3K |
- |
| 2016-05-18 |
Rotem Eran |
Deputy CEO and CFO |
Unknown |
9,000 |
$4.02 |
$36.18K |
- |
| 2016-05-18 |
Seror Jasmine |
VP Product Development |
Unknown |
1,000 |
$4.02 |
$4.02K |
- |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
